Raymond James Financial
NBP

Raymond James Financial’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Raymond James Financial’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,000
Closed -$2.42K – 5800
2025
Q2 		$2.42K Buy
+1,000
New +$1.36K ﹤0.01% 6365

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $234M AUM 640.82% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHK
Point72 Hong Kong Hong Kong $2.18B AUM 89.02% 1-Year Est. Return

Raymond James Financial's NBP Position: Q3 2025 in Review

Raymond James Financial sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2025, closing a stake of 1,000 shares — an estimated $2.42K sold.

Raymond James Financial first reported a position in NBP in Q2 2025 and held it in 1 quarter. The position peaked at $2.42K in Q2 2025. 42 funds tracked by Wall St. Rank hold NBP as of Q3 2025.

  • Raymond James Financial reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 1,000 NovaBridge Biosciences American Depositary Shares shares in Q3 2025, an estimated $2.42K.
  • Raymond James Financial first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's NovaBridge Biosciences American Depositary Shares position peaked at $2.42K in Q2 2025.
  • 42 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.